BRTX vs RL · rev $401.0K vs P/E 24, rev $8.11B
BioRestorative Therapies Inc (BRTX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
BRTX currently screens at market cap $10.2M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the BRTX and RL stock pages for the full models.
Not investment advice.